Skip to content
OpenCapital
Get started

CRISPR Therapeutics CRSP EV / sales

EV / sales at other companies

CG Oncology logo
CG OncologyCGON
1,121.8×-1,637×
Arrowhead Research logo
Arrowhead ResearchARWR
14×+10.9×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
28.9×-18.5×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
16.9×+2.2×
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-154.1×-156×
Revvity logo
RevvityRVTY
4.4×-0.9×

Other financials

Income statement

See full
Revenue$1.5M+68.6%
Operating income-$130.2M+12.2%
Net income-$122.9M+9.6%
EPS (diluted)-$1.28+19.0%

Balance sheet

See full
Cash & equivalents$423.3M+80.0%
Total debt$787.6M+259%
Total equity$1.8B-0.8%
Total assets$2.7B+25.8%

Cash flow

See full
Operating cash flow-$108.9M-102%
CapEx$504.0K+145%
Free cash flow-$109.4M-102%

Valuation

See full
Market cap$5.33B+56.4%
Enterprise value$5.69B+69.8%
P/S1,298.3×+1,208×

Profitability

See full
Operating margin-15,754.2%-17,253pp
Net margin-13,856.5%-15,058pp
FCF margin-9,777.6%-10,759pp

Returns & leverage

See full
Return on equity-31.2%+43.7pp
Debt / equity0.4×+0.3×
Current ratio18×+2.3×

Where this comes from

Calculated from CRISPR Therapeutics’s reported figures.

enterprise value/total revenue=1,201.6×

Based on the most recent quarter.

The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about CRISPR Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CRISPR Therapeutics's EV / sales?
CRISPR Therapeutics (CRSP) reported EV / sales of 1,201.6× in Q1 2026.
How has CRISPR Therapeutics's EV / sales changed year-over-year?
CRISPR Therapeutics's EV / sales increased by 1459.4% year-over-year, from 77.1× to 1,201.6×.
What is the long-term trend for CRISPR Therapeutics's EV / sales?
Over 5 years (2020 to 2025), CRISPR Therapeutics's EV / sales has grown at a -37.7% compound annual growth rate (CAGR), from 14,756.4× to 1,383.7×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.